The two radionuclides most commonly used for intra-articular therapy are '98Au and 90Y. Both emit #-radiation, which is absorbed within a small distance from the site ofemission in tissue. The decay of 198Au is also accompanied by y-radiation, which can be detected from outside the body using a scintillation detector. 90Y, however, has no y-emission, but its presence can be detected from outside the body because Bremsstrahlung is produced when the, radiation is absorbed in tissue. This radiation has a broad energy spectrum, with a peak at low energies. The intensity is much lower than that from the same radioactivity of 198Au, since only about 1 per cent. of the energy of the fl-radiation produces Bremsstrahlung when absorbed in tissue. However, since relatively large amounts of radioactivity (several mCi.) are usually administered, it is possible to detect this radiation and to measure the amount of radioactivity at a particular site in the body.
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External counting may be performed using stationary scintillation detectors, a profile scanner, a gamma camera, or an area scanner (in order of decreasing sensitivity). Quantitative rather than qualitative methods of using these instruments are more likely to prove useful in comparing different regimes of treatment, and are necessary to estimate radiation dose.
Methods
The principal physical difference between measuring 198Au and 90Y in the body is due to the absence of y-radiation from 90Y. With 198Au, the pulse height analyser can be set to include the photopeak, and there is little difficulty in discriminating against scattered radiation. With 90Y it was found best for scanning to set the pulse height analyser window equivalent to the energy range 60-200 keV. Thus, only a portion of the spectrum of Bremsstrahlung was accepted, and scattered radiation could not be ex- cluded. For quantitative scanning was related to that lost of injection (y = 0O38x -3-6; r = 076), but a less than half the loss identified with the lymph nodes, and corrections made to allow for radioactivity in adjacent tissues. The parameter which it seems most relevant to measure in assessing different radiopharmaceuticals is their retention in the treated joint, because it is this radioactivity which will produce the desired therapeutic effects. In eleven patients whose knees were injected with 90Y, uptake in lymph nodes and loss from the knee were measured by scanning. Uptake in the lymph nodes was related to loss from the knee, but accounted for only about half this loss (Figure) . This finding suggests that lymph node uptake is not a reliable guide to loss of radioactivity from the joint. It is simpler and more appropriate to measure the retention in the knee.
Calculation of radiation dose ton with a In addition to assessing a method of treatment, nterior and measurements of retention in a joint can be used in estimating the radiation dose to that joint. 9Y ymph node colloid is rapidly absorbed by synovial tissues (Webb, positively Lowe, and Bluestone, 1969; Prichard, Bridgman, and Bleehen, 1970 Jones, 1961) . The effect of loss of 90Y from the knee was expressed by calculating the ratio ofthe radiation dose delivered to the dose which would have been given had no loss occurred ('retention fraction'). Estimated radiation doses to the knee are shown in Table II . These estimates must be inaccurate because the true distribution of90Y in each knee was unknown. However, since the radiation dose estimates vary by 60 a factor of four from the highest to the lowest, it is njected dose) clear that there will be a wide variation in the radih nodes by ation doses to individual patients from the injection from the site of the same radioactivity. iccounted for Radiation doses to the lymph nodes were also estimated from uptake measurements obtained by L. Characteristics ofradio-isotopes and considerations involved in their use SuppL. p. 15 Knee scanning. The weight of these lymph nodes was assumed to be 10 g., although there could be considerable variation in this figure (Seitzman, Wright, Halaby, and Freeman, 1963) . Where uptake in lymph nodes was detected, the estimated radiation doses were typically several thousand rads (Table III) . These estimated doses have been found to be related to lymphocyte chromosome aberrations (Stevenson, Bedford, and 11 others, 1973).
Conclusion
In assessing different radiopharmaceuticals or treatment regimes for intra-articular therapy, it is useful to know the fate of the radionuclide. The preferred nuclide is probably 90Y, since it emits only fl-radiation, and the best method for measuring retention in the knee is bycounting the Bremsstrahlung with two opposed stationary detectors. Uptake in lymph nodes and liver may be of secondary importance, but the site of uptake can be positively identified by scanning and the amount of uptake determined by using dual detector quantitative scanning techniques.
Discussion
MR. CRAWLEY We have built a hybrid scanner at the Clinical Research Centre. This consists of two line detectors, one above and one below the patient, who moves on a couch between them. Electronic equipment gives whole body pictures of the anterior and posterior views of the patient, an x, y plotter gives a profile scan, and scalers can be switched in to give the total counts in any region of the body (Figs 1 and 2, overleaf) . We have used this instrument to measure leakage from the knees and to find where any isotope lost from the knees has been retained. Using a standard of 90Y we can express our results in terms of the original dose. Further refinement of the electronic circuits is in hand and it should soon be possible to distinguish the two knees automatically. At the moment we separate the knees by wrapping each one in turn in a sheet of lead.
The results ofour tests will be given in detail by Dr. Beer. Details of the hybrid scanner were given at the recent conference of radio-isotope scintigraphy at Monte Carlo (Crawley and Veall, 1973 
